NET PROFIT (x1000 EUR)
EMPLOYEES
Active Biotech AB (publ)
Closing information (x1000 EUR)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
0
![]() |
0
![]() |
0 |
Financial expenses |
21
|
48
|
6 |
Earnings before taxes |
-4,128
|
-5,245
|
-4,872 |
EBITDA |
-4,189
|
-5,202
|
-4,868 |
Total assets |
3,970
|
4,583
|
5,554 |
Current assets |
3,489
|
3,965
|
5,462 |
Current liabilities |
935
|
1,084
|
968 |
Equity capital |
2,764
|
3,101
|
4,564 |
- share capital |
168
|
123
|
110 |
Employees (average) |
8
|
9
|
8 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
69.6%
|
67.7%
|
82.2% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) |
-103.5%
|
-113.4%
|
-87.6% |
Current ratio |
373.2%
|
365.8%
|
564.3% |
Return on equity (ROE) |
-149.3%
|
-169.1%
|
-106.7% |
Change turnover |
0
![]() |
0
|
-658 |
Change turnover % | -100% | ||
Chg. No. of employees |
-1
|
1
|
-2 |
Chg. No. of employees % |
-11%
|
13%
|
-20% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.